VERX

Vertex, Inc.
$12.95
+0.18 (+1.41%)
Mkt Cap 2.10B
Volume 961,527
52W Range 10.21-26.54
Sector Technology
Beta 0.83
EPS (TTM) 0.03 USD
P/E Ratio 423.20
Revenue (TTM) 787.44M USD
Rev Growth (5Y) +14.8%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$7.83
Overvalued strong signal
65.4% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Revenue 748.44M 666.78M 572.39M 491.62M 425.55M 374.67M 321.50M 272.40M
Net Income 7.21M (52.73M) (13.09M) (12.30M) (1.48M) (75.08M) 31.06M (6.11M)
EPS 0.05 -0.34 -0.09 -0.08 -0.01 -0.60 0.21 -0.05
Free Cash Flow 47.59M 77.71M 6.10M 3.43M 46.92M 26.74M 54.94M 47.13M
FCF / Share 0.33 0.50 0.04 0.02 0.32 0.20 0.38 0.38
Operating CF 165.54M 164.82M 74.33M 63.85M 90.29M 59.54M 92.50M 80.45M
Total Assets 1.27B 1.17B 759.93M 719.19M 670.21M 558.78M 264.62M 215.07M
Total Debt 359.62M 351.89M 66.97M 73.52M 28.61M 1.11M 51.49M 54.88M
Cash & Equiv 314.01M 296.05M 68.17M 91.80M 73.33M 303.05M 75.90M 55.84M
Book Value 258.92M 179.35M 252.98M 229.72M 230.08M 229.34M (112.43M) (111.70M)
Return on Equity 0.03 -0.29 -0.05 -0.05 -0.01 -0.33 N/A N/A
VERX News
Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It
Oct 11, 2026 12:31 PM · seekingalpha.com
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
Oct 09, 2026 09:15 AM · businesswire.com
Vertex to Announce Third Quarter 2026 Financial Results November 2nd
Oct 07, 2026 12:00 PM · businesswire.com
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Oct 01, 2026 10:57 AM · fool.com
Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors
Oct 01, 2026 04:00 AM · globenewswire.com
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
Sep 29, 2026 01:10 AM · fool.com
Corient Private Wealth LP Purchases 153,840 Shares of Vertex, Inc. $VERX
Sep 24, 2026 11:15 PM · defenseworld.net
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Sep 24, 2026 04:42 AM · fool.com
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Sep 23, 2026 09:11 AM · zacks.com
Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug
Sep 22, 2026 09:55 AM · benzinga.com